Literature DB >> 18590394

Comparison of posterior fossa decompression with and without duraplasty for the surgical treatment of Chiari malformation Type I in pediatric patients: a meta-analysis.

Susan R Durham1, Kristina Fjeld-Olenec.   

Abstract

OBJECT: Surgery for Chiari malformation Type I (CM-I) is one of the most common neurosurgical procedures performed in children, although there is clearly no consensus among practitioners about which surgical method is preferred. The objective of this meta-analysis was to compare the outcome of posterior fossa decompression with duraplasty (PFDD) and posterior fossa decompression without duraplasty (PFD) for the treatment of CM-I in children.
METHODS: The authors searched Medline-Ovid, The Cochrane Library, and the conference proceedings of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons (2000-2007) for studies meeting the following inclusion criteria: 1) surgical treatment of CM-I; 2) surgical techniques of PFD and PFDD being reported in a single cohort; and 3) patient age < 18 years.
RESULTS: Five retrospective and 2 prospective cohort studies involving a total of 582 patients met the criteria for inclusion in the meta-analysis. Of the 582 patients, 316 were treated with PFDD and 266 were treated with PFD alone. Patient age ranged from 6 months to 18 years. Patients undergoing PFDD had a significantly lower reoperation rate (2.1 vs 12.6%, risk ratio [RR] 0.23, 95% confidence interval [CI] 0.08-0.69) and a higher rate of cerebrospinal fluid-related complications (18.5 vs 1.8%, RR 7.64, 95% CI 2.53-23.09) than those undergoing PFD. No significant differences in either clinical improvement (78.6 vs 64.6%, RR 1.23, 95% CI 0.95-1.59) or syringomyelia decrease (87.0 vs 56.3%, RR 1.43, 95% CI 0.91-2.25) were noted between PFDD and PFD.
CONCLUSIONS: Posterior fossa decompression with duraplasty is associated with a lower risk of reoperation than PFD but a greater risk for cerebrospinal fluid-related complications. There was no significant difference between the 2 operative techniques with respect to clinical improvement or decrease in syringomyelia.

Entities:  

Mesh:

Year:  2008        PMID: 18590394     DOI: 10.3171/PED/2008/2/7/042

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  49 in total

1.  Treatment of Chiari type I malformation in children: the experience of Lyon.

Authors:  Carmine Mottolese; Alexandru Szathmari; Emile Simon; Christophe Rousselle; Anne-Claire Ricci-Franchi; M Hermier
Journal:  Neurol Sci       Date:  2011-12       Impact factor: 3.307

Review 2.  Pathogenesis of syringomyelia associated with Chiari type 1 malformation: review of evidences and proposal of a new hypothesis.

Authors:  Izumi Koyanagi; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2010-06-08       Impact factor: 3.042

3.  Thirty-day outcomes for posterior fossa decompression in children with Chiari type 1 malformation from the US NSQIP-Pediatric database.

Authors:  Aditya Vedantam; Rory R Mayer; Kristen A Staggers; Dominic A Harris; I-Wen Pan; Sandi K Lam
Journal:  Childs Nerv Syst       Date:  2016-07-08       Impact factor: 1.475

4.  Management of Chiari I malformation in children: effectiveness of intra-operative ultrasound for tailoring foramen magnum decompression.

Authors:  Ganesalingam Narenthiran; Christopher Parks; Benedetta Pettorini
Journal:  Childs Nerv Syst       Date:  2015-04-15       Impact factor: 1.475

Review 5.  Duraplasty or not? An evidence-based review of the pediatric Chiari I malformation.

Authors:  Todd Hankinson; R Shane Tubbs; John C Wellons
Journal:  Childs Nerv Syst       Date:  2010-10-02       Impact factor: 1.475

6.  Outcomes after suboccipital decompression without dural opening in children with Chiari malformation Type I.

Authors:  Benjamin C Kennedy; Kathleen M Kelly; Michelle Q Phan; Samuel S Bruce; Michael M McDowell; Richard C E Anderson; Neil A Feldstein
Journal:  J Neurosurg Pediatr       Date:  2015-05-01       Impact factor: 2.375

7.  Treatment of Chiari malformation: who, when and how.

Authors:  Alessia Imperato; Vincenzo Seneca; Valentina Cioffi; Giuseppe Colella; Michelangelo Gangemi
Journal:  Neurol Sci       Date:  2011-12       Impact factor: 3.307

8.  Comparison of posterior fossa decompression with or without duraplasty in children with Type I Chiari malformation.

Authors:  Amy Lee; Chester K Yarbrough; Jacob K Greenberg; Jason Barber; David D Limbrick; Matthew D Smyth
Journal:  Childs Nerv Syst       Date:  2014-04-29       Impact factor: 1.475

9.  Complications and Resource Use Associated With Surgery for Chiari Malformation Type 1 in Adults: A Population Perspective.

Authors:  Jacob K Greenberg; Travis R Ladner; Margaret A Olsen; Chevis N Shannon; Jingxia Liu; Chester K Yarbrough; Jay F Piccirillo; John C Wellons; Matthew D Smyth; Tae Sung Park; David D Limbrick
Journal:  Neurosurgery       Date:  2015-08       Impact factor: 4.654

10.  Treatment of symptomatic Chiari I malformation by "all-factors-surgery": a report of 194 cases.

Authors:  Weihua Chu; Xin Chen; Xingsen Xue; Guangjian He; Jingjing Liu; Hongyan Zhang; Hua Feng; Jiangkai Lin
Journal:  Eur Spine J       Date:  2021-02-22       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.